Bacterial meningitis
MONDO:0006670Inflammation of the membranes surrounding the brain and spinal cord due to a bacterial infection.
Also known as: Bacteria caused infectious meningitis, Bacteria infectious meningitis, meningitis, bacterial
41 clinical trials for this condition and its sub-types, 12 tagged with Bacterial meningitis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Bacterial meningitis
-
Meningococcal meningitis 18 trials
-
Meningeal tuberculosis 7 trials
-
Haemophilus meningitis 1 trial
-
Escherichia coli meningitis 0 trials
-
Listeria meningitis 0 trials
-
Anaerobic meningitis 0 trials
-
1 sub-type
- Syphilitic meningitis 0 trials
-
Streptococcal meningitis 0 trials
1 sub-type
- Pneumococcal meningitis 0 trials
-
New meningitis vaccine for kids shows promise in large trial
Vaccine OngoingThis Phase 3 trial tests a new meningococcal conjugate vaccine in 660 healthy children aged 2-6 years. The vaccine targets four strains (A, C, Y, W135) that cause meningitis. Participants receive one shot and provide blood samples to compare immune response with a licensed vaccin…
Phase 3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: Vaccine
Last updated Aug 12, 2026 00:00 UTC
-
One shot to rule them all? new combo meningitis vaccine tested in teens
Vaccine OngoingThis study is testing a new vaccine called MenABCWY that aims to protect against five types of meningococcal bacteria, which can cause serious infections like meningitis. Around 312 healthy teenagers will receive two doses of the vaccine on different schedules to see how safe it …
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Vaccine
Last updated Jun 27, 2026 12:06 UTC
-
New vaccine trial aims to shield korean babies from deadly meningitis
Vaccine OngoingThis study tests the MenB+OMV NZ vaccine in 50 healthy infants starting at 2 months old in South Korea. The vaccine is given as three shots over about a year to see if it triggers a strong immune response against meningococcal group B bacteria, which can cause meningitis. Researc…
Phase 4 • Sponsor: GlaxoSmithKline • Aim: Vaccine
Last updated Jun 27, 2026 12:04 UTC
-
New vaccine study aims to shield toddlers from deadly meningitis
Vaccine OngoingThis study tests a vaccine designed to protect young children from four types of meningitis bacteria. Researchers gave the vaccine to 660 toddlers aged 6 to 23 months and will check their immune response over time. Some children will also receive a booster shot at age 3 to see if…
Phase 4 • Sponsor: CanSino Biologics Inc. • Aim: Vaccine
Last updated Jun 27, 2026 09:10 UTC